Potential Anti-Apoptotic Impacts and Telomerase Activity of Royal Jelly on Different Tissues of Rats
Archives of Medical Laboratory Sciences,
Vol. 8 (2022),
10 January 2022
,
Page 1-8 (e3)
https://doi.org/10.22037/amls.v8.36534
Abstract
ackground and Aim: Royal jelly (RJ) has a broad range of pharmaceutical activities, including antioxidant, anti-aging, anti-tumor, and anti-apoptotic. The current study aimed to investigate RJ impacts on cell survival by measuring the amount of telomerase enzyme, protein BCL2, and BAX in different tissues of rats.
Methods: In this study, male Wistar rats (n=21) were randomly divided into 3 groups; Group 1 was the control group. Group 2 and group 3 were treated with royal jelly at a concentration of 150 mg/kg and 300 mg/kg for 30 days, respectively. The contents of Bax, BCL-2, and telomerase in the tissues Brain, Liver, Kidney, and lymphocytes were measured using the ELISA method.
Results: Telomerase increased in all the tissues involved in both treatment groups compared to the control group; however, the changes were not statistically significant. Although BAX and BCL-2 proteins showed irregular patterns, the ratio of BAX/BCL-2 declined in almost all the studied tissues with a significant decline in the rats’ liver and kidney treated with RJ at the dose of 300 mg/kg and in the lymphocytes of the group administered 150 mg/kg of RJ.
Conclusion: RJ appears to have potential anti-apoptotic effects on the rats’ tissues studied via regulating the levels of BAX, BCL-2, and telomerase proteins. Regarding telomerase, its levels increased in a dose-dependent manner in all involved tissues. Concerning the ratio of BAX/BCL-2, it is sensible to conclude that RJ tends to positively impact the cell survival rate at the dose of 300 mg/kg in the brain, Liver, and Kidney. Nonetheless, this ratio decreased more significantly at the dose of 150 mg/kg in lymphocytes, showing more potential to survive brain cells in this concentration.
*Corresponding Author: Seyed-Hosein Abtahi-Eivary; Email: Abtahi.h@gmu.ac.ir;
ORCID ID:0000-0001-5807-8933
Please cite this article as: Khani-Eshratabadi M, Talebpour A, Bagherzadeh A, Mehranfar P, Motallebzadeh Khanmiri J, Ghorbani M, Abtahi-Eivary SH. Potential Anti-Apoptotic Impacts and Telomerase Activity of Royal Jelly on Different Tissues of Rats. Arch Med Lab Sci. 2022;8:1-10 (e3). https://doi.org/10.22037/amls.v8.36534
- Apoptosis
- BAX
- BCL2
- Royal Jelly
- Telomerase
How to Cite
References
Hou J, Xie W, Hong D, Zhang W, Li F, Qian Y, et al. Simultaneous determination of ten neonicotinoid insecticides and two metabolites in honey and Royal-jelly by solid− phase extraction and liquid chromatography− tandem mass spectrometry. Food chemistry. 2019;270:204-13.
Li M, Wang D, He J, Chen L, Li H. Bcl-xl: A multifunctional anti-apoptotic protein. Pharmacological research. 2020;151:104547.
Kiraz Y, Adan A, Yandim MK, Baran Y. Major apoptotic mechanisms and genes involved in apoptosis. Tumor Biology. 2016;37(7):8471-86.
Wong RS. Apoptosis in cancer: from pathogenesis to treatment. Journal of Experimental & Clinical Cancer Research. 2011;30(1):1-14.
Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clinical cancer research. 2009;15(4):1126-32.
Gu H, Song I-B, Han H-J, Lee N-Y, Cha J-Y, Son Y-K, et al. Antioxidant activity of royal jelly hydrolysates obtained by enzymatic treatment. Korean journal for food science of animal resources. 2018;38(1):135.
Xin X-x, Chen Y, Chen D, Xiao F, Parnell LD, Zhao J, et al. Supplementation with major royal-jelly proteins increases lifespan, feeding, and fecundity in Drosophila. Journal of agricultural and food chemistry. 2016;64(29):5803-12.
Froushani SMA, Delirezh N, Hobbenaghi R, Mosayebi G. Therapeutic effects of all-trans retinoic acid on experimental autoimmune encephalomyelitis and its role in T-helper lymphocyte responses. Tehran University Medical Journal. 2012;69(11).
Ishii R, Horie M, Murayama M, Maitani T. Analysis of tetracyclines in honey and royal jelly by LC/MS/MS. Shokuhin eiseigaku zasshi Journal of the Food Hygienic Society of Japan. 2006;47(6):277-83.
Madar J, Malý E, Neubauer E, Moscovic F. Effect of bee royal jelly (gelee royale) on the cholesterol level, total lipids in the serum and on the fibrinolytic activity of plasma of elderly arteriosclerotic patients. Zeitschrift fur Alternsforschung. 1965;18(2):103-8.
Vucevic D, Melliou E, Vasilijic S, Gasic S, Ivanovski P, Chinou I, et al. Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro. International immunopharmacology. 2007;7(9):1211-20.
Abdelatif M, Yakoot M, Etmaan M. Safety and efficacy of a new honey ointment on diabetic foot ulcers: a prospective pilot study. Journal of wound care. 2008;17(3):108-10.
Pasupuleti VR, Sammugam L, Ramesh N, Gan SH. Honey, propolis, and royal jelly: a comprehensive review of their biological actions and health benefits. Oxidative medicine and cellular longevity. 2017;2017.
Iannuzzi J. ROYAL JELLY-MYSTERY FOOD. 1. American Bee Journal. 1990;130(8):532-4.
Ramanathan ANKG, Nair AJ, Sugunan VS. A review on Royal Jelly proteins and peptides. Journal of Functional Foods. 2018;44:255-64.
Šver L, Oršolić N, Tadić Z, Njari B, Valpotic I, Bašic I. A royal jelly as a new potential immunomodulator in rats and mice. Comparative immunology, microbiology and infectious diseases. 1996;19(1):31-8.
Park MJ, Kim BY, Deng Y, Park HG, Choi YS, Lee KS, et al. Antioxidant capacity of major royal jelly proteins of honeybee (Apis mellifera) royal jelly. Journal of Asia-Pacific Entomology. 2020;23(2):445-8.
Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nature reviews Molecular cell biology. 2008;9(1):47-59.
Prieto-Oliveira P. Telomerase activation in the treatment of aging or degenerative diseases: a systematic review. Molecular and Cellular Biochemistry. 2021;476(2):599-607.
Jenkhetkan W, Thitiorul S, Jansom C, Ratanavalachai T. Molecular and cytogenetic effects of Thai royal jelly: modulation through c-MYC, h-TERT, NRF2, HO-1, BCL2, BAX and cyclins in human lymphocytes in vitro. Mutagenesis. 2017;32(5):525-31.
Ghanbari E, Khazaei MR, Khazaei M, Nejati V. Royal jelly promotes ovarian follicles growth and increases steroid hormones in immature rats. International journal of fertility & sterility. 2018;11(4):263.
Karadeniz A, Simsek N, Karakus E, Yildirim S, Kara A, Can I, et al. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxidative medicine and cellular longevity. 2011;2011.
Mohamed AA-R, Galal AA, Elewa YH. Comparative protective effects of royal jelly and cod liver oil against neurotoxic impact of tartrazine on male rat pups brain. Acta Histochemica. 2015;117(7):649-58.
Zahmatkesh E, Najafi G, Nejati V, Heidari R. Protective effect of royal jelly on the sperm parameters and testosterone level and lipid peroxidation in adult mice treated with oxymetholone. Avicenna journal of phytomedicine. 2014;4(1):43.
Kruger NJ. The Bradford method for protein quantitation. The protein protocols handbook. 2009:17-24.
Jiang C-m, Liu X, Li C-x, Qian H-c, Chen D, Lai C-q, et al. Anti-senescence effect and molecular mechanism of the major royal jelly proteins on human embryonic lung fibroblast (HFL-I) cell line. Journal of Zhejiang University-SCIENCE B. 2018;19(12):960-72.
Didar G, Delpazir F, Kaviani M, Azarpira N, Sepehrara L, Ebadi P, et al. Influence of mesenchymal stem cells and royal jelly on kidney damage triggered by ischemia-reperfusion injury: comparison with ischemic preconditioning in an animal model. Comparative Clinical Pathology. 2019;28(2):311-20.
Almeer RS, AlBasher GI, Alarifi S, Alkahtani S, Ali D, Moneim AEA. Royal jelly attenuates cadmium-induced nephrotoxicity in male mice. Scientific reports. 2019;9(1):1-12.
Aslan A, Beyaz S, Gok O, Can MI, Parlak G, Ozercan IH, et al. Royal jelly abrogates flouride-induced oxidative damage in rat heart tissue by activating of the nrf-2/NF-κB and bcl-2/bax pathway. Toxicology Mechanisms and Methods. 2021;31(9):644-54.
Aslan A, Gok O, Beyaz S, Can MI, Parlak G, Gundogdu R, et al. Royal jelly regulates the caspase, Bax and COX-2, TNF-α protein pathways in the fluoride exposed lung damage in rats. Tissue and Cell. 2022;76:101754.
Hashem KS, Elkelawy AMMH, Abd-Allah S, Helmy NA. Involvement of Mfn2, Bcl2/Bax signaling and mitochondrial viability in the potential protective effect of Royal jelly against mitochondria-mediated ovarian apoptosis by cisplatin in rats. Iranian Journal of Basic Medical Sciences. 2020;23(4):515.
Neamatallah T, El-Shitany NA, Abbas AT, Ali SS, Eid BG. Honey protects against cisplatin-induced hepatic and renal toxicity through inhibition of NF-κB-mediated COX-2 expression and the oxidative stress dependent BAX/Bcl-2/caspase-3 apoptotic pathway. Food & function. 2018;9(7):3743-54.
Almeer RS, Alarifi S, Alkahtani S, Ibrahim SR, Ali D, Moneim A. The potential hepatoprotective effect of royal jelly against cadmium chloride-induced hepatotoxicity in mice is mediated by suppression of oxidative stress and upregulation of Nrf2 expression. Biomedicine & Pharmacotherapy. 2018;106:1490-8.
Hosseini SE, Delerezh N, Afzal Ahangaran N. Effect of Royal Jelly on Peripheral Blood Mononuclear Cells Cytotoxicity against the K562 Erythroleukemia Cell Line. Journal of Mazandaran University of Medical Sciences. 2014;24(114):1-7.
Almeer RS, Kassab RB, AlBasher GI, Alarifi S, Alkahtani S, Ali D, et al. Royal jelly mitigates cadmium-induced neuronal damage in mouse cortex. Molecular biology reports. 2019;46(1):119-31.
- Abstract Viewed: 223 times
- PDF Downloaded: 102 times